Public Calendar: October 15 - 21, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date : 10/16/2017 - 10/16/2017
Location : Washington, DC
Subject : National Organization for Rare Disorders: 2017 Rare Diseases and Orphan Products Breakthrough Summit
FDA Participant/Group : KATHLEEN QUINN; ROBERT TEMPLE; PETER MARKS; JEFFREY SHUREN;
Non FDA Participant/Group : Healthcare professionals, academia, industry representatives, media ,and other registered individuals
Event Date : 10/16/2017 - 10/16/2017
Location : Washington, DC
Subject : The National Academy of Medicine President's Forum: The U.S. Opioid Epidemic
FDA Participant/Group : KATHLEEN QUINN;
Non FDA Participant/Group : Healthcare professionals, academia, industry representatives, media, and other registered individuals
Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : National Institute for Health Care Management Foundation Board Meeting
FDA Participant/Group : MAARIKA KIMBRELL;
Non FDA Participant/Group : Several members (National Institute for Health Care Management Foundation );
Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : American Clinical Laboratory Association Board Meeting
FDA Participant/Group : LAUREN SILVIS;
Non FDA Participant/Group : Several members (American Clinical Laboratory Association);
Event Date : 10/19/2017 - 10/19/2017
Location : Baltimore, MD
Subject : The U.S. Food and Drug Administration's Framework: Nicotine Regulation
FDA Participant/Group : MITCHELL ZELLER; MICHAEL FELBERBAUM;
Non FDA Participant/Group : Several faculty, students, and staff (Johns Hopkins Bloomberg School of Public Health );
Event Date : 10/20/2017 - 10/20/2017
Location : Silver Spring, MD
Subject : Recent Developments Related to Antibiotic Development and Diagnostics
FDA Participant/Group : CARA TENENBAUM; MAARIKA KIMBRELL; STEVEN GITTERMAN; LAUREN SILVIS; PETER MARKS; SUMATHI NAMBIAR; EDWARD COX; KATHLEEN QUINN; ELIZABETH HILLEBRENNER; JOSEPHINE TROPEA; JEFFREY SHUREN; KATHERINE SCHUMANN;
Non FDA Participant/Group : Helen Boucher; Kimberly Hanson; Amanda Jezek; Jaclyn Levy (Infectious Diseases Society of America); Sue Ramthun (Hart Health Strategies);
Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
Event Date : 10/19/2017
Location : Marana, AZ
Subject : Council for Responsible Nutrition: FDA Priorities for Dietary Supplements & Functional Food
FDA Participant/Group : N/A
Non FDA Participant/Group : Several members (Council for Responsible Nutrition);
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
No Significant Event
Official Name : CAPT Denise Hinton, Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : National Organization for Rare Disorders 2017 Rare Diseases and Orphan Products Breakthrough Summit: Advancing Products for Rare Diseases
FDA Participant/Group : JEFFREY SHUREN;Several FDA officials and staff members
Non FDA Participant/Group : N/A
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : National Organization for Rare Disorders 2017 Rare Diseases and Orphan Products Breakthrough Summit: Rare Disease Drug, Biologic and Device Development: Achievements and Opportunities
FDA Participant/Group : PETER MARKS;Several FDA officials and staff members
Non FDA Participant/Group : N/A
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name : Rebecca K. Wood, J.D., Chief Counsel
No Significant Event